학술논문
Receptor for hyaluronan‐mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Document Type
Article
Author
Tarullo, Sarah E; He, Yuyu; Daughters, Claire; Knutson, Todd P; Henzler, Christine M; Price, Matthew A; Shanley, Ryan; Witschen, Patrice; Tolg, Cornelia; Kaspar, Rachael E; Hallstrom, Caroline; Gittsovich, Lyubov; Sulciner, Megan L; Zhang, Xihong; Forster, Colleen L; Lange, Carol A; Shats, Oleg; Desler, Michelle; Cowan, Kenneth H; Yee, Douglas
Source
Journal of Pathology; Jul2023, Vol. 260 Issue 3, p289-303, 15p
Subject
Language
ISSN
00223417
Abstract
Copyright of Journal of Pathology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)